Literature DB >> 30252594

Direct screening of plasma circulating microRNAs.

Paola Songia1,2, Mattia Chiesa1,3, Vincenza Valerio1,2, Donato Moschetta1,2, Veronika A Myasoedova1,2, Yuri D'Alessandra1,3, Paolo Poggio1,2.   

Abstract

Circulating microRNAs (miRNAs) are considered as reliable candidates for biomarker discovery. RNA-Sequencing has become the most suitable technique to accurately quantify the miRNAome. However, RNA-Sequencing relies on several technical passages before reaching the final-end. HTG EdgeSeq technology, thanks to the abrogation of RNA extraction step, allows productivity enhancement by reducing the number of hands-on steps, the time for sample preparation and, therefore, the costs. We found a strong correlation between qPCR and dPCR with HTG (Pearson's coefficient of 0.93 and 0.94, respectively). In conclusion, we showed that HTG EdgeSeq, performed on human plasma specimens without RNA extraction, is reliable, allows the simultaneous screening of more than 2,000 miRNAs, and thus, it could be applied to biomarker discovery in large cohorts.

Entities:  

Keywords:  HTG EdgeSeq; digital PCR; direct quantification; miRNAome; quantitative PCR

Mesh:

Substances:

Year:  2018        PMID: 30252594      PMCID: PMC6284556          DOI: 10.1080/15476286.2018.1526538

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  12 in total

Review 1.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

2.  An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.

Authors:  Luc Girard; Jaime Rodriguez-Canales; Carmen Behrens; Debrah M Thompson; Ihab W Botros; Hao Tang; Yang Xie; Natasha Rekhtman; William D Travis; Ignacio I Wistuba; John D Minna; Adi F Gazdar
Journal:  Clin Cancer Res       Date:  2016-06-28       Impact factor: 12.531

Review 3.  Non-coding RNAs as regulators of gene expression and epigenetics.

Authors:  Minna U Kaikkonen; Michael T Y Lam; Christopher K Glass
Journal:  Cardiovasc Res       Date:  2011-05-09       Impact factor: 10.787

4.  Control of RNA processing by a large non-coding RNA over-expressed in carcinomas.

Authors:  Rui Lin; Manami Roychowdhury-Saha; Chris Black; Andrew T Watt; Eric G Marcusson; Susan M Freier; Thomas S Edgington
Journal:  FEBS Lett       Date:  2011-01-23       Impact factor: 4.124

Review 5.  MicroRNAs in Cardiovascular Disease.

Authors:  Temo Barwari; Abhishek Joshi; Manuel Mayr
Journal:  J Am Coll Cardiol       Date:  2016-12-13       Impact factor: 24.094

6.  Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction.

Authors:  S Robinson; M Follo; D Haenel; M Mauler; D Stallmann; M Tewari; D Duerschmied; K Peter; C Bode; I Ahrens; M Hortmann
Journal:  Int J Cardiol       Date:  2018-04-15       Impact factor: 4.164

7.  The microRNA spectrum in 12 body fluids.

Authors:  Jessica A Weber; David H Baxter; Shile Zhang; David Y Huang; Kuo How Huang; Ming Jen Lee; David J Galas; Kai Wang
Journal:  Clin Chem       Date:  2010-09-16       Impact factor: 8.327

Review 8.  Control of Chromatin Structure by Long Noncoding RNA.

Authors:  Gudrun Böhmdorfer; Andrzej T Wierzbicki
Journal:  Trends Cell Biol       Date:  2015-10       Impact factor: 20.808

Review 9.  Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.

Authors:  Ahmed S Bayoumi; Tatsuya Aonuma; Jian-Peng Teoh; Yao-Liang Tang; Il-Man Kim
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

10.  Addressing Bias in Small RNA Library Preparation for Sequencing: A New Protocol Recovers MicroRNAs that Evade Capture by Current Methods.

Authors:  Jeanette Baran-Gale; C Lisa Kurtz; Michael R Erdos; Christina Sison; Alice Young; Emily E Fannin; Peter S Chines; Praveen Sethupathy
Journal:  Front Genet       Date:  2015-12-22       Impact factor: 4.599

View more
  6 in total

1.  Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.

Authors:  Yoko Koh; Matias A Bustos; Jamie Moon; Rebecca Gross; Romela Irene Ramos; Suyeon Ryu; Jane Choe; Selena Y Lin; Warren M Allen; David L Krasne; Timothy G Wilson; Dave S B Hoon
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 2.  MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?

Authors:  Claire Lozano; Isabelle Duroux-Richard; Hüseyin Firat; Eric Schordan; Florence Apparailly
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

Review 3.  Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis.

Authors:  Francesca Precazzini; Simone Detassis; Andrea Selenito Imperatori; Michela Alessandra Denti; Paola Campomenosi
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

4.  Extraction-Free Absolute Quantification of Circulating miRNAs by Chip-Based Digital PCR.

Authors:  Yuri D'Alessandra; Vincenza Valerio; Donato Moschetta; Ilaria Massaiu; Michele Bozzi; Maddalena Conte; Valentina Parisi; Michele Ciccarelli; Dario Leosco; Veronika A Myasoedova; Paolo Poggio
Journal:  Biomedicines       Date:  2022-06-08

5.  Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes.

Authors:  Eiichiro Satake; Pierre-Jean Saulnier; Hiroki Kobayashi; Manoj K Gupta; Helen C Looker; Jonathan M Wilson; Zaipul I Md Dom; Katsuhito Ihara; Kristina O'Neil; Bozena Krolewski; Caterina Pipino; Meda E Pavkov; Viji Nair; Markus Bitzer; Monika A Niewczas; Matthias Kretzler; Michael Mauer; Alessandro Doria; Behzad Najafian; Rohit N Kulkarni; Kevin L Duffin; Marcus G Pezzolesi; C Ronald Kahn; Robert G Nelson; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2021-06-17       Impact factor: 14.978

6.  A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin.

Authors:  David S Moura; Maria Peña-Chilet; Juan Antonio Cordero Varela; Ramiro Alvarez-Alegret; Carolina Agra-Pujol; Francisco Izquierdo; Rafael Ramos; Luis Ortega-Medina; Francisco Martin-Davila; Carolina Castilla-Ramirez; Carmen Nieves Hernandez-Leon; Cleofe Romagosa; Maria Angeles Vaz Salgado; Javier Lavernia; Silvia Bagué; Empar Mayodormo-Aranda; Luis Vicioso; Jose Emilio Hernández Barceló; Jordi Rubio-Casadevall; Ana de Juan; Maria Concepcion Fiaño-Valverde; Nadia Hindi; Maria Lopez-Alvarez; Serena Lacerenza; Joaquin Dopazo; Antonio Gutierrez; Rosa Alvarez; Claudia Valverde; Javier Martinez-Trufero; Javier Martín-Broto
Journal:  Mol Oncol       Date:  2021-06-30       Impact factor: 6.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.